Mitsuharu Ueda

Mitsuharu Ueda

Auto-generated profile, based on publicly available information

Mitsuharu Ueda

A Department of Neurology , Graduate School of Medical Sciences, Kumamoto University , Kumamoto , Japan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
MUMitsuharu Ueda
Mitsuharu Ueda
YMYohei Misumi
Yohei Misumi
MMMineyuki Mizuguchi
Mineyuki Mizuguchi
MNMasaaki Nakamura
Masaaki Nakamura
TYTaro Yamashita
Taro Yamashita
YAYusuke Ando
Yusuke Ando
Background: Mass spectrometric analyses are valuable for detection of transthyretin (TTR) variants, which cause familial amyloidotic polyneuropathy (FAP). However, those methods require an immunoprecipitation step with an anti-TTR antibody and are not suitable for quantitative detection. We investigated the usefulness of SELDI-TOF mass spectrometry (MS) without an immunoprecipitation step. Methods: We used ProteinChips with chromatographic capture formats to detect TTRs. We attempted to correlate the intensity of mixed samples of amyloidogenic TTR (ATTR) V30M to wild-type (WT) TTR. We analyzed the proportion of ATTR V30M in amyloid-laden cardiac tissues from FAP patients, and also evaluated samples from FAP patients with 16 other TTR mutations. Results: Detection of ATTR required only 3 h of SELDI-TOF MS analysis. We determined that SELDI-TOF MS was suitable for quantitative detection of ATTR V30M and demonstrated that the proportion of ATTR V30M to WT TTR was 46.6% in amyloid-laden cardiac tissue from an FAP patient who died 10 years after liver transplantation. With this method, we identified 12 of 17 TTR variants. Small mass shifts and low concentrations of variants prevented ATTR detection. By changing the analytical conditions, we achieved detection of low concentrations of ATTR Y114C in serum. Conclusions: SELDI-TOF MS is a reliable tool for quantitative evaluation of TTR variants, in both tissue amyloid deposits and body fluids. This method is useful for the diagnosis and investigation of the pathogenesis of FAP.

11 February 2011 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
KOKonen Obayashi
Konen Obayashi
TYTaro Yamashita
Taro Yamashita
MTMasayoshi Tasaki
Masayoshi Tasaki
MUMitsuharu Ueda
Mitsuharu Ueda
MSMakoto Shono
Makoto Shono
YAYusuke Ando
Yusuke Ando

1 September 2010 in International Journal of Oncology
Verified
Journal Article
Closed access
PDF file
ANAndo
Ando
KOKazutoshi Ota
Kazutoshi Ota
HFHiromi Fujimori
Hiromi Fujimori
MUMitsuharu Ueda
Mitsuharu Ueda
HJHirofumi Jono
Hirofumi Jono
YAYusuke Ando
Yusuke Ando
Midkine (MK) expression has been documented to be inversely correlated with the prognosis of patients with various tumors, but the mechanism of this relationship has not been well characterized. Recent studies have also correlated p53 expression with prognosis of patients with oral squamous cell carcinoma (OSCC). We evaluated the relationship between MK expression and clinicopathological features of patients with OSCC to clarify the influence of p53 status on MK expression in OSCC cells. Our results showed that patients with MK over-expression in OSCC cells had a significantly lower 5-year survival rate compared with patients with low MK expression. Immunohistochemical analyses demonstrated overexpression of MK protein in OSCC samples with mutant p53. Cell culture experiments with human lingual squamous cell carcinoma revealed that the MK gene was regulated by the wild-type p53 gene. Thus, MK expression may affect prognosis via the p53 status and mutation of the p53 gene, and MK may be an attractive target for therapeutic intervention in patients with cancer cells with mutant p53.

1 January 2006 in Amyloid
Verified
Journal Article
Closed access
XSXuguo Sun
Xuguo Sun
MUMitsuharu Ueda
Mitsuharu Ueda
TYTaro Yamashita
Taro Yamashita
MLMárcia Liz
Márcia Liz
JBJoakim Bergstrom
Joakim Bergstrom
YAYusuke Ando
Yusuke Ando
It has been well documented that transthyretin (TTR) shows an affinity for lipoproteins and amyloid is deposited around adipocytes in patients with familial amyloidotic polyneuropathy (FAP). We examined the involvement of lipids in amyloid fibrils in the tissues by histopathologic methods. Sudan black B staining for frozen tissues of autopsied FAP patients and biospied dialysis related amyloidosis (DRA) patients revealed colocalization of lipids in the tissue sections where Congo red staining was positive, while no such positive staining was observed in paraffin embedded tissues. Immunohistochemical study using lipoprotein antibodies revealed that only anti-high density lipoprotein (HDL) antibody showed immunoreactivity in both types of amyloid specimens where Congo red was positively stained. Measurement of the components of lipids in the frozen cardiac samples from an FAP patient and an amyotrophic lateral sclerosis (ALS) patient revealed that concentrations of triglyceride and cholesterol in each lipoprotein, except for HDL-triglyceride, were markedly elevated in the FAP patient's material, compared to that of the ALS patient. These results suggest that interaction of amyloid fibrils with HDL may play an important role in amyloid formation in FAP.


24 May 2012 in Amyloid
Verified
Journal Article
Closed access
PDF file
HJHirofumi Jono
Hirofumi Jono
TATakayuki Anno
Takayuki Anno
KMKeiichi Motoyama
Keiichi Motoyama
YMYohei Misumi
Yohei Misumi
MTMasayoshi Tasaki
Masayoshi Tasaki
YAYusuke Ando
Yusuke Ando
Transthyretin (TTR)-related familial amyloidotic polyneuropathy, which is induced by amyloidogenic transthyretin (ATTR), is characterized by systemic accumulation of amyloid fibrils. Although it is believed that protein misfolding of monomeric form of TTR is a rate-limiting step for TTR amyloid formation, no effective therapy targeting this misfolding step is available. Our recent studies revealed that cyclodextrins (CyDs), cyclic oligosaccharides composed of glucose units, might interact with TTR and prevent the protein misfolding. In this study, we focused on and elucidated the inhibitory effect of 6-O-α-(4-O-α-d-Glucuronyl)-d-glucosyl-β-CyD (GUG-β-CyD) on TTR amyloid formation. Tryptophan (Trp) fluorescence and 1H-NMR spectroscopy analyses indicated that GUG-β-CyD stabilized TTR conformation via interaction with the hydrophobic amino acids of TTR. Moreover, GUG-β-CyD suppressed TTR deposition in transgenic rats possessing a human ATTR V30M gene in vivo. Collectively, these data indicate that GUG-β-CyD may inhibit TTR misfolding by stabilizing its conformation, which, in turn, suppresses TTR amyloid formation.